Using your head to tackle influenza diversity
Cell Host & Microbe · 2026
DOI: 10.1016/j.chom.2026.04.003 ↗Kurz gefasst
Kommentar in der Zeitschrift Cell Host & Microbe, 2026. Verfasst von Marios Koutsakos und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Austral…. Hauptthemen laut MEDLINE: Influenza A Virus, H3N2 Subtype, Hemagglutinin Glycoproteins, Influenza Virus, Antibodies, Monoclonal, Influenza A Virus, H1N1 Subtype. Die Arbeit nennt 8 Literaturangaben. Gefördert von: National Health and Medical Research Council.
Abstract (Originalsprache)
Influenza viruses are notoriously diverse, challenging the development of effective countermeasures. In two recent Cell Host & Microbe studies, Li et al. and Cai et al. describe monoclonal antibodies against the hemagglutinin head domain that can cross-neutralize A(H1N1) and A(H3N2) subtypes or drifted influenza B viruses, respectively.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Immunology, University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.
- Department of Microbiology and Immunology, University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia. Electronic address: a.wheatley@unimelb.edu.au.
Förderung
- National Health and Medical Research Council
Zitieren
APA
Koutsakos, M., & Wheatley, A. K. (2026). Using your head to tackle influenza diversity. Cell Host & Microbe. https://doi.org/10.1016/j.chom.2026.04.003
Vancouver
Koutsakos M, Wheatley AK. Using your head to tackle influenza diversity. Cell Host & Microbe. 2026. doi:10.1016/j.chom.2026.04.003
BibTeX
@article{Koutsakos2026,
author = {Koutsakos, Marios and Wheatley, Adam K},
title = {Using your head to tackle influenza diversity},
journal = {Cell Host & Microbe},
year = {2026},
doi = {10.1016/j.chom.2026.04.003}
}
EUVIMED